Efficacy and Safety of Different Intravenous Glucocorticoid Regimens in the Treatment of Graves' Ophthalmopathy: A Meta-Analysis

PURPOSE: The intravenous glucocorticoid (iv GC) represents the mainstay of therapy for Graves' ophthalmopathy (GO), but uncertainty remains concerning the optimal regimen. Although the European Group on Graves' Orbitopathy (EUGOGO) regimen has been commonly employed, evidence for its super...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jing, Xu, Nuo, Sun, Huilan, Chen, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289584/
https://www.ncbi.nlm.nih.gov/pubmed/34336262
http://dx.doi.org/10.1155/2021/9799274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289584/
https://www.ncbi.nlm.nih.gov/pubmed/34336262
http://dx.doi.org/10.1155/2021/9799274

Ejemplares similares